Lyell Immunopharma Inc (LYEL)

Apr 02, 2025

Lyell Immunopharma director Otis Brawley purchases shares for $19,958 - Investing.com India

Apr 02, 2025

Apr 02, 2025

Lyell Immunopharma stock hits 52-week low at $0.48 - Investing.com

Apr 02, 2025

Apr 02, 2025

Lyell Immunopharma stock hits 52-week low at $0.48 By Investing.com - Investing.com South Africa

Apr 02, 2025

Apr 01, 2025

Lyell Immunopharma to close West Hills facility, cut 73 jobs - Investing.com

Apr 01, 2025

Apr 01, 2025

Lyell Immunopharma’s LyFE Center Begins IMPT-314 Production - TipRanks

Apr 01, 2025

Apr 01, 2025

Lyell Immunopharma IncTo Close West Hills Manufacturing FacilitySEC Filing - MarketScreener

Apr 01, 2025

Mar 31, 2025

Lyell Immunopharma, Inc. (NASDAQ:LYEL) Sees Significant Decline in Short Interest - MarketBeat

Mar 31, 2025

Mar 31, 2025

Charles Schwab Investment Management Inc. Has $1.05 Million Holdings in Lyell Immunopharma, Inc. (NASDAQ:LYEL) - Defense World

Mar 31, 2025

Mar 28, 2025

Is Lyell Immunopharma, Inc. (LYEL) the Cheapest Stock Insiders Are Buying In March? - Insider Monkey

Mar 28, 2025

Mar 25, 2025

Lyell Immunopharma director Ramachandra Sumant purchases $115,219 in stock - Investing.com

Mar 25, 2025

Mar 25, 2025

Lyell Immunopharma director Ramachandra Sumant purchases $115,219 in stock By Investing.com - Investing.com South Africa

Mar 25, 2025

Mar 23, 2025

Investor Interest in Lyell Immunopharma Stock (LYEL) Surges on Positive Analyst Report - markets.businessinsider.com

Mar 23, 2025

Mar 20, 2025

Favourable Signals For Lyell Immunopharma: Numerous Insiders Acquired Stock - Yahoo Finance

Mar 20, 2025

Mar 20, 2025

Chief Financial Officer of Lyell Immunopharma Charles Newton Buys 989% More Shares - simplywall.st

Mar 20, 2025

Mar 19, 2025

How to interpret Lyell Immunopharma Inc (LYEL)’s stock chart patterns - US Post News

Mar 19, 2025

Mar 19, 2025

Lyell Immunopharma stock hits 52-week low at $0.51 By Investing.com - Investing.com Australia

Mar 19, 2025

Mar 19, 2025

Lyell Immunopharma director Richard Klausner purchases $94,942 in stock - Investing.com India

Mar 19, 2025

Mar 18, 2025

Lyell Immunopharma CEO Seely Lynn buys $106,190 in stock By Investing.com - Investing.com South Africa

Mar 18, 2025

Mar 18, 2025

Lyell Immunopharma director Richard Klausner purchases $94,942 in stock By Investing.com - Investing.com Canada

Mar 18, 2025

Mar 18, 2025

Lyell Immunopharma CFO Newton purchases $111,620 in common stock By Investing.com - Investing.com South Africa

Mar 18, 2025

Mar 18, 2025

Lyell Immunopharma CEO Seely Lynn buys $106,190 in stock - Investing.com India

Mar 18, 2025

Mar 18, 2025

Lyell Immunopharma CFO Newton purchases $111,620 in common stock - Investing.com India

Mar 18, 2025

Mar 18, 2025

Lyell Immunopharma stock hits 52-week low at $0.51 - Investing.com India

Mar 18, 2025

Mar 18, 2025

Lyell Immunopharma’s Global Expansion Strategy: Navigating Risks and Challenges - TipRanks

Mar 18, 2025

Mar 17, 2025

HC Wainwright Has Optimistic Outlook of LYEL Q1 Earnings - Defense World

Mar 17, 2025

Mar 15, 2025

Lyell Immunopharma (NASDAQ:LYEL) Earns Neutral Rating from HC Wainwright - Defense World

Mar 15, 2025

Mar 13, 2025

H.C. Wainwright maintains Neutral on Lyell Immunopharma stock By Investing.com - Investing.com Australia

Mar 13, 2025

Mar 12, 2025

Lyell Immunopharma Advances CAR T-Cell Therapy Pipeline - TipRanks

Mar 12, 2025

Mar 11, 2025

Lyell Immunopharma reports Q4 net loss $45.9M vs. net loss $44M last year - TipRanks

Mar 11, 2025

Mar 11, 2025

Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2024 - GlobeNewswire

Mar 11, 2025

Mar 11, 2025

Breakthrough: Lyell's Cancer Therapy Achieves 94% Response Rate Amid Q4 Financial Results - StockTitan

Mar 11, 2025

Mar 06, 2025

BlackRock, Inc. Reduces Stake in Lyell Immunopharma Inc - GuruFocus.com

Mar 06, 2025

Feb 20, 2025

Lyell Immunopharma (LYEL) Projected to Post Earnings on Wednesday - MarketBeat

Feb 20, 2025

Feb 19, 2025

Lyell Immunopharma Announces Participation in Upcoming Investor Conferences - The Manila Times

Feb 19, 2025

Feb 18, 2025

LYELLyell Immunopharma, Inc. Latest Stock News & Market Updates - StockTitan

Feb 18, 2025

Feb 18, 2025

Cell Therapy Pioneer Lyell to Showcase Cancer Treatment Breakthroughs at Elite Investor Events - StockTitan

Feb 18, 2025

Feb 18, 2025

What Did We Find About Insider Trading At Lyell Immunopharma Inc (NASDAQ: LYEL)? - Stocks Register

Feb 18, 2025

Feb 17, 2025

Lyell Immunopharma (LYEL) Upgraded to Strong Buy: Here's Why - MSN

Feb 17, 2025

Feb 17, 2025

Following a 67% decline over last year, recent gains may please Lyell Immunopharma, Inc. (NASDAQ:LYEL) institutional owners - Simply Wall St

Feb 17, 2025

Feb 14, 2025

SG Americas Securities LLC Has $75,000 Position in Lyell Immunopharma, Inc. (NASDAQ:LYEL) - Defense World

Feb 14, 2025

Feb 10, 2025

Market Recap Check: Lyell Immunopharma Inc (LYEL)’s Negative Finish at 0.57, Up/Down -2.94 - The Dwinnex

Feb 10, 2025

Feb 07, 2025

Lyell Immunopharma Inc (LYEL) Stock: A Year of Market Fluctuations - The InvestChronicle

Feb 07, 2025

Feb 06, 2025

Take off with Lyell Immunopharma Inc (LYEL): Get ready for trading - SETE News

Feb 06, 2025

Feb 04, 2025

LYEL underperforms with a -0.98 decrease in share price - US Post News

Feb 04, 2025

Feb 04, 2025

Market Momentum Report: Lyell Immunopharma Inc (LYEL)’s Negative Close at 0.58 - The Dwinnex

Feb 04, 2025

Jan 31, 2025

Lyell Immunopharma, Inc. (NASDAQ:LYEL) has caught the attention of institutional investors who hold a sizeable 46% stake - Yahoo Finance

Jan 31, 2025

Jan 25, 2025

Lyell Immunopharma Faces Nasdaq delisting over share price - MSN

Jan 25, 2025

Jan 25, 2025

Lyell Immunopharma Faces Nasdaq delisting over share price By Investing.com - Investing.com Australia

Jan 25, 2025